API Family
Bendroflumethiazide
Storage Condition
Refer MSDS for complete information
Synonyms
4-Nitroso-3-((phenyl-d5)methyl)-6-(trifluoromethyl)-3,4-dihydro-2H-benzo[e][1,2,4]thiadiazine-7-sulfonamide 1,1-Dioxide
Application Notes
Useful research chemical for a range of applications
Hazard Compound
Refer MSDS for complete information
N-Nitroso rac Bendroflumethiazide-D5 is a drug product that is used as an analytical standard for HPLC, as well as in research and development of drugs.
Refund Policy
We are committed to offering products of the highest quality in order to meet the needs of our customers, and have elaborate systems in
place to ensure that material specifications, their certification and all handling and storage conditions are communicated at the time of
material handover.
We have invested in the highest quality packaging materials and use international logistics partners to service our customers. While all
possible precautions have been taken to deliver the required product(s), there may be some rare situations when our product does not
meet your requirements. Should that arise, please contact us with your concerns and we will endeavour to address them on a priority
basis. If there is no other option, we will either replace your product(s) or issue a refund or account credit, whichever you prefer.
If there is an issue with one or more of our products, our policy is that it must be reported to us within 45 days of your receiving shipment.
While we will always address product issues after the 45 day return window has passed, we cannot issue a refund or account credit. As
always, we appreciate your support.
N-Nitroso rac Bendroflumethiazide-D5 usage and description
N-Nitroso rac Bendroflumethiazide-D5 is a chemical compound used in research and clinical settings for its potential applications in the treatment of hypertension and other cardiovascular diseases. It is a stable isotope-labeled form of the drug bendroflumethiazide, which is a thiazide diuretic commonly used to treat high blood pressure.
The addition of the N-Nitroso group to bendroflumethiazide-D5 increases its bioavailability and potency, allowing for enhanced therapeutic effects. However, it is important to note that N-Nitroso compounds have been shown to have potential carcinogenic properties, and thus further research is needed to fully understand the safety and efficacy of this compound.
Chemically, N-Nitroso rac Bendroflumethiazide-D5 is a nitrosourea derivative with a molecular formula of C17H14D5ClN3O4S2. Its mechanism of action involves inhibiting the reabsorption of sodium and chloride ions in the distal convoluted tubules of the kidneys, leading to increased urinary excretion and decreased blood volume and pressure.
Overall, N-Nitroso rac Bendroflumethiazide-D5 shows promise as a potential therapeutic agent for hypertension and other cardiovascular conditions. However, further research is needed to fully understand its safety and efficacy, particularly with regards to its potential carcinogenic properties.
